Kasuga Chinatsu, Nakahara Yukiko, Ueda Shigeo, Hawkins Cynthia, Taylor Michael D, Smith Christian A, Rutka James T
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Ontario, Canada.
J Neurosurg Pediatr. 2008 Apr;1(4):305-13. doi: 10.3171/PED/2008/1/4/305.
Cancer testis antigens (CTAs) were initially identified by their ability to elicit autologous T-cell-mediated immune responses in patients with melanoma. The CTA genes are widely expressed in a variety of human cancers, such as melanoma, breast cancer, lung cancer, esophageal cancer, and hepatocellular carcinoma; however, their expression in pediatric brain tumors, such as medulloblastoma (MB), has not been the subject of in-depth analysis. The MAGE proteins are members of the CTA family and have been shown to correlate with tumor development, aggressive clinical course, or resistance to chemotherapeutic agents. The authors undertook this study to examine the expression and role of MAGE proteins in human MB cell lines and specimens.
From a transcriptional profiling study in which 47,000 genes in MB cell lines were examined, the authors identified members of the MAGE and GAGE families as being highly expressed. A series of MB tumors was examined using both immunohistochemistry and Western blot analysis with antibodies to the MAGE-A family, MAGE-A1, and GAGE proteins.
Western blot analysis showed expression of these 3 proteins (MAGE-A family, MAGE-A1, and GAGE) in 62, 46, and 84%, respectively, of MB specimens examined. In addition, a correlation was observed between the expression of MAGE and GAGE genes and resistance of MB cells to chemotherapeutic agents. The functional significance of this correlation was examined in MAGE knockdown studies, and increased drug-induced cytotoxicity was observed in UW426 MB cells following treatment with chemotherapeutic drugs. Cleaved caspase-3 was found in UW426/MAGE small interfering (si)RNA-inhibited cells treated with cisplatin, but not in UW426 cells treated with cisplatin alone at the same concentration.
These data show that MAGE and GAGE family members are expressed in MB cell lines and specimens, and that inhibition of MAGE and GAGE genes by siRNA increases apoptosis of MB cells and sensitizes them to certain chemotherapeutic agents such as cisplatin and etoposide.
癌睾丸抗原(CTA)最初是因其在黑色素瘤患者中引发自体T细胞介导的免疫反应的能力而被鉴定出来的。CTA基因在多种人类癌症中广泛表达,如黑色素瘤、乳腺癌、肺癌、食管癌和肝细胞癌;然而,它们在小儿脑肿瘤如髓母细胞瘤(MB)中的表达尚未成为深入分析的主题。MAGE蛋白是CTA家族的成员,已被证明与肿瘤发展、侵袭性临床病程或对化疗药物的耐药性相关。作者进行了这项研究,以检查MAGE蛋白在人MB细胞系和标本中的表达及作用。
在一项对MB细胞系中的47000个基因进行检测的转录谱研究中,作者确定MAGE和GAGE家族成员高度表达。使用针对MAGE - A家族、MAGE - A1和GAGE蛋白的抗体,通过免疫组织化学和蛋白质印迹分析对一系列MB肿瘤进行检测。
蛋白质印迹分析显示,在所检测的MB标本中,这三种蛋白(MAGE - A家族、MAGE - A1和GAGE)的表达率分别为62%、46%和84%。此外,观察到MAGE和GAGE基因的表达与MB细胞对化疗药物的耐药性之间存在相关性。在MAGE基因敲低研究中对这种相关性的功能意义进行了检测,在用化疗药物处理后,UW426 MB细胞中观察到药物诱导的细胞毒性增加。在用顺铂处理的UW426/MAGE小干扰(si)RNA抑制细胞中发现了裂解的半胱天冬酶 - 3,但在相同浓度下单独用顺铂处理的UW426细胞中未发现。
这些数据表明,MAGE和GAGE家族成员在MB细胞系和标本中表达,并且通过siRNA抑制MAGE和GAGE基因可增加MB细胞的凋亡,并使它们对某些化疗药物如顺铂和依托泊苷敏感。